Physician profile
Patrick H Dillon
NPI 1952531683
$10,395.11
in general payments reported to CMS, 2019-2025
13 companies · $2,968 in 2025
The $2,968 reported for 2025 was more than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,596 · 2020: $2,193 · 2021: $219 · 2022: $3,038 · 2023: $110 · 2024: $272 · 2025: $2,968.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $2,625 · Food and Beverage: $725.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $2,625.00 |
| Food and Beverage | $724.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik INC. | $3,162.45 | 2019-2022 | |
| Biosense Webster, INC. | $3,146.74 | 2020-2025 | Carto 3, Octaray Mapping Catheter, Qdot Micro Catheter |
| Medtronic Vascular, INC. | $2,522.94 | 2019-2020 | |
| Boston Scientific Corporation | $911.52 | 2019-2025 | Farapulse, General - Therapies |
| Pfizer INC. | $245.78 | 2019-2020 | |
| Abbott Laboratories | $95.90 | 2019-2024 | Jot Dx |
| Medtronic, INC. | $94.21 | 2021-2024 | Plasmablade(Tm) |
| Atricure, INC. | $86.56 | 2024 | |
| Amgen INC. | $43.29 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $29.70 | 2019-2020 | |
| Impulse Dynamics (USA) INC. | $25.10 | 2024 | Optimizer |
| Boehringer Ingelheim Pharmaceuticals, INC. | $22.96 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $7.96 | 2024-2025 | Lifevest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Dillon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.